The University of Warwick Library - WebBridge
Neo-tAnGo: a neoadjuvant randomized phase III trial of epirubicin/cyclophosphamide and paclitaxel +/- gemcitabine in the treatment of women with high-risk early breast cancer (EBC): first report of the primary endpoint, pathological complete response (pCR)
Earl,
Helena M..
45th Annual Meeting of the American Society of Clinical Oncology.
v.
Vol.27.
no.
No.15 Suppl. S.
2009-05-20.
p.
60 -
issn:
0732-183X
.
Sorry - based on the information provided, WebBridge cannot offer appropriate links.